These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 30631322)

  • 1.
    Bezerra-Santos M; do Vale-Simon M; Barreto AS; Cazzaniga RA; de Oliveira DT; Barrios MR; Ferreira AR; Santos-Bio NC; Reed SG; de Almeida RP; Corrêa CB; Duthie MS; de Jesus AR
    Front Immunol; 2018; 9():2920. PubMed ID: 30631322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct Roles of Th17 and Th1 Cells in Inflammatory Responses Associated with the Presentation of Paucibacillary Leprosy and Leprosy Reactions.
    Santos MB; de Oliveira DT; Cazzaniga RA; Varjão CS; Dos Santos PL; Santos MLB; Correia CB; Faria DR; Simon MDV; Silva JS; Dutra WO; Reed SG; Duthie MS; de Almeida RP; de Jesus AR
    Scand J Immunol; 2017 Jul; 86(1):40-49. PubMed ID: 28426172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antigen-specific secretion of IFNγ and CXCL10 in whole blood assay detects Mycobacterium leprae infection but does not discriminate asymptomatic infection from symptomatic leprosy.
    Hungria EM; Freitas AA; Pontes MA; Gonçalves HS; Sousa AL; Costa MB; Castilho ML; Duthie MS; Stefani MM
    Diagn Microbiol Infect Dis; 2017 Apr; 87(4):328-334. PubMed ID: 28126361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergistic antigen combinations for the development of interferon gamma release assays for paucibacillary leprosy.
    Oliveira RM; Hungria EM; de Araújo Freitas A; de Sousa AL; Costa MB; Reed SG; Duthie MS; Stefani MM
    Eur J Clin Microbiol Infect Dis; 2014 Aug; 33(8):1415-24. PubMed ID: 24619112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interruption of persistent exposure to leprosy combined or not with recent BCG vaccination enhances the response to Mycobacterium leprae specific antigens.
    de Carvalho FM; Rodrigues LS; Duppre NC; Alvim IMP; Ribeiro-Alves M; Pinheiro RO; Sarno EN; Pessolani MCV; Pereira GMB
    PLoS Negl Trop Dis; 2017 May; 11(5):e0005560. PubMed ID: 28467415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serodiagnosis of paucibacillary and multibacillary leprosy using a recombinant chimeric protein composed of specific B-cell epitopes derived from Mycobacterium leprae proteins.
    Assis BPN; Chaves AT; Lage DP; Cardoso MM; Freitas CS; Pereira IAG; Câmara RSB; Martins VT; de Oliveira ALG; Machado-de-Ávila RA; Galdino AS; Chávez-Fumagalli MA; Christodoulides M; Gonçalves DU; Bueno LL; Fujiwara RT; Coelho EAF; da Costa Rocha MO
    Tuberculosis (Edinb); 2024 Jul; 147():102505. PubMed ID: 38583359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Host immune responses induced by specific Mycobacterium leprae antigens in an overnight whole-blood assay correlate with the diagnosis of paucibacillary leprosy patients in China.
    Chen X; You YG; Yuan YH; Yuan LC; Wen Y
    PLoS Negl Trop Dis; 2019 Apr; 13(4):e0007318. PubMed ID: 31017900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interferon-gamma (IFN-gamma) and tumour necrosis factor-alpha (TNF-alpha) are necessary in the early stages of induction of CD4 and CD8 cytotoxic T cells by Mycobacterium leprae heat shock protein (hsp) 65 kD.
    Sasiain MC; de la Barrera S; Fink S; Finiasz M; Alemán M; Fariña MH; Pizzariello G; Valdez R
    Clin Exp Immunol; 1998 Nov; 114(2):196-203. PubMed ID: 9822276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Humoral and cellular immune reactivity to recombinant M. leprae antigens in HLA-typed leprosy patients and healthy controls.
    Klatser PR; Janson AM; Thole JE; Buhrer S; Bos C; Soebono H; de Vries RR
    Int J Lepr Other Mycobact Dis; 1997 Jun; 65(2):178-89. PubMed ID: 9251589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and pre-clinical assessment of a 73 kD chimeric fusion protein as a defined sub-unit vaccine for leprosy.
    Duthie MS; Sampaio LH; Oliveira RM; Raman VS; O'Donnell J; Bailor HR; Ireton GC; Sousa AL; Stefani MM; Reed SG
    Vaccine; 2013 Jan; 31(5):813-9. PubMed ID: 23228811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protection against Mycobacterium leprae infection by the ID83/GLA-SE and ID93/GLA-SE vaccines developed for tuberculosis.
    Duthie MS; Coler RN; Laurance JD; Sampaio LH; Oliveira RM; Sousa AL; Stefani MM; Maeda Y; Matsuoka M; Makino M; Reed SG
    Infect Immun; 2014 Sep; 82(9):3979-85. PubMed ID: 25024362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunological cytokine correlates of protective immunity and pathogenesis in leprosy.
    Lima MC; Pereira GM; Rumjanek FD; Gomes HM; Duppre N; Sampaio EP; Alvim IM; Nery JA; Sarno EN; Pessolani MC
    Scand J Immunol; 2000 Apr; 51(4):419-28. PubMed ID: 10736116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcription factors STAT-4, STAT-6 and CREB regulate Th1/Th2 response in leprosy patients: effect of M. leprae antigens.
    Upadhyay R; Dua B; Sharma B; Natrajan M; Jain AK; Kithiganahalli Narayanaswamy B; Joshi B
    BMC Infect Dis; 2019 Jan; 19(1):52. PubMed ID: 30642265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antigen-specific assessment of the immunological status of various groups in a leprosy endemic region.
    da Conceição Oliveira Coelho Fabri A; Carvalho AP; Araujo S; Goulart LR; de Mattos AM; Teixeira HC; Goulart IM; Duthie MS; Correa-Oliveira R; Lana FC
    BMC Infect Dis; 2015 May; 15():218. PubMed ID: 26021317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Presence of human T-cell responses to the Mycobacterium leprae 45-kilodalton antigen reflects infection with or exposure to M. leprae.
    Macfarlane A; Mondragon-Gonzalez R; Vega-Lopez F; Wieles B; de Pena J; Rodriguez O; Suarez y de la Torre R; de Vries RR; Ottenhoff TH; Dockrell HM
    Clin Diagn Lab Immunol; 2001 May; 8(3):604-11. PubMed ID: 11329466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antigen-specific T-cell responses of leprosy patients.
    Duthie MS; Goto W; Ireton GC; Reece ST; Sampaio LH; Grassi AB; Sousa AL; Martelli CM; Stefani MM; Reed SG
    Clin Vaccine Immunol; 2008 Nov; 15(11):1659-65. PubMed ID: 18784342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunologically reactive M. leprae antigens with relevance to diagnosis and vaccine development.
    Sampaio LH; Stefani MM; Oliveira RM; Sousa AL; Ireton GC; Reed SG; Duthie MS
    BMC Infect Dis; 2011 Jan; 11():26. PubMed ID: 21269435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utility of immunoglobulin isotypes against LID-1 and NDO-LID for, particularly IgG1, confirming the diagnosis of multibacillary leprosy.
    Marçal PHF; Fraga LAO; Mattos AMM; Menegati L; Coelho ADCO; Pinheiro RO; Sarno EN; Duthie MS; Teixeira HC
    Mem Inst Oswaldo Cruz; 2018; 113(5):e170467. PubMed ID: 29513821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protection against Mycobacterium tuberculosis infection offered by a new multistage subunit vaccine correlates with increased number of IFN-γ+ IL-2+ CD4+ and IFN-γ+ CD8+ T cells.
    Wang X; Zhang J; Liang J; Zhang Y; Teng X; Yuan X; Fan X
    PLoS One; 2015; 10(3):e0122560. PubMed ID: 25822536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential development of CD4 and CD8 cytotoxic T cells (CTL) in PBMC across the leprosy spectrum; IL-6 with IFN-gamma or IL-2 generate CTL in multibacillary patients.
    de la Barrera S; Finiasz DM; Fink S; Valdez R; Bottasso O; Balina LM; Sasiain MC
    Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):45-55. PubMed ID: 9207753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.